GlassScriptPhysician profile
Andi Huang
NPI 1295230837
$3,719.28
in general payments reported to CMS, 2019-2025
18 companies · $1,312 in 2025
The $1,312 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $955 · 2022: $596 · 2023: $123 · 2024: $733 · 2025: $1,312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,021 · Education: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,021.18 |
| Education | $147.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $639.50 | 2021-2025 | |
| Janssen Biotech, INC. | $624.10 | 2021-2025 | Tremfya |
| Genzyme Corporation | $472.85 | 2021-2025 | |
| Incyte Corporation | $314.51 | 2024-2025 | Opzelura |
| Sun Pharmaceutical Industries INC. | $302.98 | 2021-2024 | |
| Novartis Pharmaceuticals Corporation | $221.50 | 2021-2022 | |
| Lilly USA, LLC | $211.27 | 2021-2025 | Ebglyss, Taltz |
| Pfizer INC. | $201.80 | 2021-2025 | |
| Arcutis Biotherapeutics, INC. | $197.79 | 2024-2025 | Zoryve |
| Galderma Laboratories, L.P. | $161.04 | 2024-2025 | Nemluvio, Aklief |
| Boehringer Ingelheim Pharmaceuticals, INC. | $92.21 | 2024 | Cyltezo, Spevigo |
| Leo Pharma INC. | $83.11 | 2024-2025 | Adbry, Anzupgo |
| Regeneron Healthcare Solutions, INC. | $71.57 | 2022-2025 | Dupixent |
| Amgen INC. | $43.72 | 2021 | |
| Mayne Pharma Commercial LLC | $27.76 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $22.14 | 2021 | |
| Ucb, INC. | $16.23 | 2021 | |
| Aytu Biopharma, INC. | $15.20 | 2024 | Karbinal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andi Huang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.